Detalhe da pesquisa
1.
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
J Transl Med
; 21(1): 725, 2023 10 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37845764
2.
Combi-TED: a new trial testing Tedopi® with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line.
Future Oncol
; 18(40): 4457-4464, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36946237
3.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32539942
4.
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.
Proc Natl Acad Sci U S A
; 112(48): 14924-9, 2015 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26627242
5.
Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.
Oncologist
; 20(8): 880-9, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26099741
6.
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.
Lung Cancer
; 187: 107444, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38157806
7.
Targeting c-MET in the battle against advanced nonsmall-cell lung cancer.
Curr Opin Oncol
; 25(2): 130-6, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23385860
8.
Pretreated EGFRdel19/BRAFV600E Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case Report.
JTO Clin Res Rep
; 4(8): 100545, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37533438
9.
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.] / Gestione del paziente con microcitoma a stadio esteso. L'importanza della collaborazione tra oncologia e radioterapia.
Recenti Prog Med
; 114(7): 414-425, 2023.
Artigo
Italiano
| MEDLINE | ID: mdl-37392104
10.
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.
Lung Cancer
; 180: 107215, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37126920
11.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov
; 13(7): 1556-1571, 2023 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37068173
12.
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Transl Oncol
; 23: 101471, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35779323
13.
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.] / Gestione del paziente con microcitoma nelle regioni Lazio, Umbria e Sardegna.
Recenti Prog Med
; 112(10): 639-646, 2021 10.
Artigo
Italiano
| MEDLINE | ID: mdl-34647533
14.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Eur J Cancer
; 150: 224-231, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33934059
15.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
J Immunother Cancer
; 9(4)2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33827906
16.
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Eur J Cancer
; 148: 24-35, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33721704
17.
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Thorac Cancer
; 12(6): 880-889, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33527756
18.
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study.
ESMO Open
; 5(4)2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32817059
19.
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer.
Oncotarget
; 10(5): 561-572, 2019 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30728907
20.
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer.
J Immunother Cancer
; 7(1): 316, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31752994